EU Authorized Representative for Malaysia: Where Examination and Surgical Gloves Part Company

A pinprick decides which glove needs a notified body

Malaysian plants ship examination gloves and surgical gloves off adjacent lines, in the same halls, against the same EN 455 test programme, with the same latex or nitrile compound. Under Malaysian law both sit inside the same Act 737 registration machinery. Under MDR they are not the same kind of product at all, and the reason is a definition most glove files have never had to read.

The Commission’s classification guidance MDCG 2021-24 explains that a surgically invasive device always enters through an artificially created opening, and that the opening can be a surgical incision or a pinprick made by a needle — which is why surgical gloves and needles used with syringes are treated as surgically invasive. Examination gloves therefore fall under Annex VIII Rule 5, invasive with respect to body orifices, transient use, class I. Surgical gloves fall under Rule 6: "All surgically invasive devices intended for transient use are classified as class IIa unless they:" (MDR Annex VIII, Chapter III, Rule 6). Class IIa is a notified body class end to end, not a sterility-only involvement.

Where each Malaysian glove line actually lands

The table below is the version of this we draw on a whiteboard in the first meeting. It is worth noting how far apart the third and fourth rows are, given how close the products are on the factory floor.

A glove that protects the wearer is also PPE, and 2016/425 does not step aside

The PPE Regulation lists harmful biological agents among the Category III risks, and it does not exclude products that are also medical devices. A glove marketed to protect the patient is a device; the same glove marketed to protect the healthcare worker from blood-borne pathogens is Category III personal protective equipment, requiring EU type-examination under Annex V of that Regulation plus either supervised product checks or production quality assurance. Most Malaysian glove ranges are sold on both claims.

The Regulation anticipates exactly this overlap: "Where, concerning aspects not covered by this Regulation, devices are subject to other Union legislation which also requires an EU declaration of conformity by the manufacturer that fulfilment of the requirements of that legislation has been demonstrated, a single EU declaration of conformity shall be drawn up in respect of all Union acts applicable to the device." (MDR Art. 19(2)) One declaration, both instruments identified in it, and under Article 20(6) the CE marking then signifies compliance with both. What it does not mean is one assessment. Two conformity assessment procedures run, frequently with two different bodies, and a marketing claim about wearer protection written by a sales team can quietly commit the plant to the second one.

A CAB certificate under Act 737 is not a notified body certificate

Malaysia is unusual in the region for having devolved conformity assessment to independent bodies. Under the Medical Device Act 2012 a device must be registered before it can be imported, exported or placed on the market, and for Class B, C and D that registration is built on a conformity assessment certificate issued by a Conformity Assessment Body registered with the Medical Device Authority. Class A is exempted from the CAB procedure under the Medical Device (Exemption) Order 2016.

Structurally this looks European: a third party, registered by the state, assessing QMS, technical documentation, post-market surveillance and the declaration of conformity. It is worth being precise about why it still does not travel. A notified body is designated under MDR Article 42 by a Member State authority, audited jointly under Article 44, and constrained to the procedures in Annexes IX to XI; the certificate it issues is the instrument that permits CE marking. A CAB registration under Act 737 confers none of that. The audit findings, the QMS evidence and the technical file content are all reusable — the certificate is not.

Act 737 already uses these words, pointing the other way

Malaysian regulatory staff are usually the first to spot the symmetry: a manufacturer whose principal place of business is outside Malaysia registers through an authorised representative appointed for that purpose. The role Medex performs for a Malaysian manufacturer in the Union is that role reflected. The reflection is imperfect in one important respect. Under MDR Article 11(5), where the manufacturer is outside the Union and has not complied with Article 10, the representative is legally liable for defective devices jointly and severally with the manufacturer. The obligations that cannot be delegated at all — Article 10(1) to (4), (6), (7) and (9) to (12), covering risk management, clinical evaluation, technical documentation, the QMS and the conformity assessment itself — stay in Malaysia under MDR Article 11(4).

Sterility, shelf life and the records a first audit opens

Glove files that have only ever faced EN 455 and a CAB review tend to be thin in three predictable places. Sterilisation validation for the sterile lines has to be current and specific to the load configurations actually run, not inherited from a validation performed years earlier on a different chamber. Shelf-life justification has to be real-time or properly bridged accelerated data tied to the specific compound, because ageing behaviour of natural rubber latex is compound-dependent. And biological evaluation under Annex I Section 10.1 has to address residual proteins and vulcanisation accelerators as a materials question, not as a labelling statement. Powder-free is a specification, not an argument.

Getting the mandate and the registrations in place from Kuala Lumpur

Medex holds EUDAMED authorised representative SRN TR-AR-000057550 and is separately registered as a manufacturer, TR-MF-000057496, and as an importer. The person responsible for regulatory compliance is in-house — a partner of the firm, with a named deputy — rather than an outsourced signature. Offices in Ankara, İstanbul and Gdańsk mean the Union-side registered place of business and the day-to-day file work sit in the same organisation. Fees are class-based and published, from EUR 1000 a year; actor and device registration is handled as part of the same engagement, described on our EUDAMED registration page.

What Malaysian glove and device manufacturers ask

We hold MDA registrations for both our examination and surgical ranges. Why is Europe treating them differently?

Because MDR classifies by how the device interacts with the body, and a surgical glove is treated as surgically invasive on the reasoning that it enters through an artificially created opening. That puts it in Rule 6 and class IIa, with a full notified body assessment, while the examination range stays class I. Two products, two routes, two very different timelines and costs.

Our CAB issued a conformity assessment certificate covering our QMS. Does a notified body have to accept it?

No. It has no standing under MDR and a notified body cannot rely on it. The underlying material is another matter: audit reports, process validations, supplier controls and CAPA records are all usable evidence, and a well-run CAB file usually shortens preparation considerably even though it shortens the assessment not at all. Talk to us before the notified body application so the reusable parts are identified first.

If we only claim patient protection, can we avoid the PPE Regulation entirely?

In principle yes — the PPE route follows the protective claim. In practice this has to be enforced across the label, the instructions for use, the catalogue and the tender responses, because a wearer-protection claim made anywhere by anyone in your distribution chain drags the product into Regulation (EU) 2016/425. Decide it deliberately and write it into the labelling controls.